Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension.
文献摘要
Transitioning from selexipag to parenteral prostacyclin analogues yielded haemodynamic improvement. Outcomes are poor among those within this population who do not achieve a low-risk status after the transition. https://bit.ly/4sMY3aF.